Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Latest filing published 02 Oct 2026 for Spyre Therapeutics, Inc., €47k. Read the official filing
Filing timeline
BuySaleCameron Turtle
Insider track record
Disclosed buys
0
Disclosed sells
28
Signal history
Cameron Turtle: trading record in brief
Cameron Turtle is a declared insider of Spyre Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 24 November 2023 to 1 October 2026, the count stands at 30 filings.
The open-market record consists of 28 sales worth €6.5M, with no purchase. Outside the open market, there are 1 share grant. 2026 to date brings no purchases and 26 sales.
The record was last updated on 2 October 2026 with an open-market sale (€47k) in Spyre Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cameron Turtle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
600 shares@ US$89.140.0007% mcap0.7% of flowCommon StockSEC:0001636282-26-000118:0
2,683 shares@ US$90.100.0033% mcap3.3% of flowCommon StockSEC:0001636282-26-000118:1
2,638 shares@ US$91.490.0033% mcap3.3% of flowCommon StockSEC:0001636282-26-000118:2
3,989 shares@ US$92.310.0050% mcap5.0% of flowCommon StockSEC:0001636282-26-000118:3
4,990 shares@ US$93.370.0063% mcap6.3% of flowCommon StockSEC:0001636282-26-000118:4
100 shares@ US$93.910.0001% mcap0.1% of flowCommon StockSEC:0001636282-26-000118:5
2,500 shares@ US$86.360.0028% mcap3.5% of flowCommon StockSEC:0001636282-26-000107:0
8,400 shares@ US$87.150.0095% mcap11.8% of flowCommon StockSEC:0001636282-26-000107:1
3,700 shares@ US$88.060.0042% mcap5.3% of flowCommon StockSEC:0001636282-26-000107:2
400 shares@ US$89.070.0005% mcap0.6% of flowCommon StockSEC:0001636282-26-000107:3
800 shares@ US$93.970.0010% mcap1.2% of flowCommon StockSEC:0001636282-26-000099:0
7,157 shares@ US$95.100.0089% mcap11.1% of flowCommon StockSEC:0001636282-26-000099:1
5,635 shares@ US$95.930.0071% mcap8.8% of flowCommon StockSEC:0001636282-26-000099:2
1,392 shares@ US$96.820.0018% mcap2.2% of flowCommon StockSEC:0001636282-26-000099:3
16 shares@ US$97.460.0000% mcap0.0% of flowCommon StockSEC:0001636282-26-000099:4
3,600 shares@ US$70.770.0032% mcap4.1% of flowCommon StockSEC:0001758363-26-000009:1
1,700 shares@ US$74.230.0016% mcap2.0% of flowCommon StockSEC:0001758363-26-000009:4
300 shares@ US$74.960.0003% mcap0.4% of flowCommon StockSEC:0001758363-26-000009:5
5,300 shares@ US$69.540.0047% mcap5.9% of flowCommon StockSEC:0001758363-26-000009:0
1,000 shares@ US$71.760.0009% mcap1.1% of flowCommon StockSEC:0001758363-26-000009:2
3,100 shares@ US$73.140.0029% mcap3.6% of flowCommon StockSEC:0001758363-26-000009:3
12,344 shares@ US$49.209.8% of flowCommon StockSEC:0001758363-26-000007:0
2,656 shares@ US$49.922.1% of flowCommon StockSEC:0001758363-26-000007:1
5,900 shares@ US$41.733.9% of flowCommon StockSEC:0001636282-26-000026:0
957 shares@ US$31.820.5% of flowCommon StockSEC:0001758363-26-000005:0
25 of 30 declarations
